• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Why I'm Banking on UBS

The company remains one of the biggest players in the investment world.
By DAVE BUTLER
Jan 22, 2019 | 03:00 PM EST
Stocks quotes in this article: UBS

Despite the underwhelming fourth quarter results, I don't really see a reason to sell my shares of UBS Group (UBS) . The company remains one of the biggest players in the investment world. I don't think rough market conditions will change that over the long term. Do I think we'll see some continued volatility through the first half of 2019? It's very likely; but the dividend yield and strong cash position are what I am interested in for the short term. Short-term volatility only matters if you need liquidity, in which case you probably shouldn't be invested anyway.

UBS suffered from outflows of client money in their wealth management business. This isn't that crazy when you consider market conditions. The bank reported that clients pulled $13 billion in assets in the fourth quarter. That's a lot of money and the effects that it could have on their revenue from wealth management will probably last into 2019 unless UBS see's a reversal. Its understandable to see some people protect their wealth from the fourth quarter marketplace. The effects of uncertainty over the ongoing Brexit ordeal, coupled with concerns about the European economy certainly echoed in the minds of investors. It's not shocking to see clients move to cash. I certainly share the sentiment that cash is king right now. That said, the current market offers opportunities for long-term plays. I couldn't resist buying some UBS a few weeks ago.

Fourth-quarter earnings overshadowed a successful year for the bank. Operating income declined 3.2% to $6.97 billion. I won't really compare the fourth quarter's net earnings of $696 million to the prior year's as UBS' fourth quarter 2017 included losses from U.S. tax reforms make the comparison less meaningful. On a pretax basis, the bank did well. Operating profit before taxes increased 2% year over year to $862 million. Net earnings did come in below expectations of $729 million from analysts; largely prompting the nearly 5% pullback today at the time of writing.

No doubt the next few weeks will be clouded by reverberating fears that UBS is losing a big chunk of its managed assets. The stock will be mixed. It's understandable to not like seeing investors pull $8 billion from the bank's wealth management group and another $5 billion from asset management -- but it's not the end of the world. I view it as a symptom of market sentiment itself, not UBS. Naturally a decrease in managed assets of $13 billion will certainly dampen revenue potential moving forward, so we must look at the stock from an earnings perspective.

Fourth-quarter earnings were $0.18 per diluted share. Once again, the effects of last year's tax reforms make comparing the earnings to last year's loss of $0.72 a share a less meaningful endeavor. UBS finished the year with $1.27 in earnings per share; giving the stock a valuation of 10.26x earnings at the time of writing. UBS didn't really provide numerical guidance in its earnings release; instead simply stating that the effects of the capital outflows and market conditions would continue to weigh on revenues in the first quarter of 2019. I won't venture to guess what this will mean over the course of the year. I expect Q1'19 to be very similar to Q4'18. My presumption is that the cheap nature of the stock at present provides insulation from the lower assets at hand. Barring any massive further disruptions to revenue, I think things will be okay over the long run. Short term you're taking the volatility in order to ride the dividend.

I am looking at UBS as a long-term investment in diversified financial services. They work in every major market, and offer a strong yield at a low valuation right now. Yes, there are concerns of slowing worldwide growth. But over the long term, shares in UBS should pay off. I am considering adding to my position in the next few weeks if the markets pull shares down further. At the end of the fourth quarter, the bank had over $108 billion in cash/balances on hand. I am in no way concerned for their ability to maintain their 5% dividend payments. Coupled with the announced plan of $1 billion in share buybacks this year, I think UBS is offering a nice deal for those willing to collect interest and hold it for the long haul. In times of strife, people are inclined to pull their money. That doesn't mean they won't want those time tested asset managers to manage it again when conditions improve.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication Butler had a position in UBS.

TAGS: Investing

More from Investing

Bearish Bets: 2 NYSE Stocks You Should Consider Shorting This Week

Bob Lang
Jan 24, 2021 10:30 AM EST

These names are displaying both quantitative and technical deterioration.

Price Targets: How They Mislead and How They Can be Used

James "Rev Shark" DePorre
Jan 23, 2021 10:00 AM EST

The main problem with price targets is that they are a static number in a dynamic situation.

Stock Market Continues to Defy Conventional Wisdom

James "Rev Shark" DePorre
Jan 22, 2021 5:04 PM EST

Concerns about the action being overheated remain, but rotational action keeps the momentum going.

AMC Is a High Risk, High Reward Play

Timothy Collins
Jan 22, 2021 2:15 PM EST

Short and sweet: This is based on the high running emotions of the markets. There's little to it beyond that.

GoodRx Needs a Shot in the Arm to Improve Its Outlook

Bruce Kamich
Jan 22, 2021 2:03 PM EST

IPOs in recent months have done extremely well -- not so GDRX.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:01 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    I discuss price targets in my Saturday column.
  • 07:54 AM EST GARY BERMAN

    Friday Morning Fibocall for 1/22/2021

    SPX (Long-Term View) The 1/21/21 NEW high @ 3861...
  • 11:16 AM EST CHRIS VERSACE

    Worst Stocks to Buy for the Biden Presidency

    Biden's take on the minimum wage, likely moves on ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login